No increased insulin sensitivity after a single intravenous administration of a recombinant human tumor necrosis factor receptor: Fc fusion protein in obese insulin-resistant patients

Journal of Clinical Endocrinology and Metabolism

Volumn 85, Issue 3, 2000, Pages 1316-1319

  Paquot, N ^a   Castillo, M J ^a   Lefebvre P J ^a   Scheen, A J ^a  

^a CHU SART TILMAN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; LENERCEPT; TUMOR NECROSIS FACTOR ALPHA;

ADULT; CALORIMETRY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE CLAMP TECHNIQUE; HUMAN; HYPERINSULINEMIA; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC CLEARANCE RATE; OBESITY; PRIORITY JOURNAL; REVIEW; SINGLE BLIND PROCEDURE;

ADULT; BLOOD GLUCOSE; FEMALE; HUMANS; HYPERINSULINISM; IMMUNOGLOBULIN GAMMA-CHAINS; IMMUNOGLOBULIN HEAVY CHAINS; INJECTIONS, INTRAVENOUS; INSULIN; INSULIN RESISTANCE; MALE; MIDDLE AGED; OBESITY; RECEPTORS, TUMOR NECROSIS FACTOR; RECOMBINANT FUSION PROTEINS; RECOMBINANT PROTEINS; SINGLE-BLIND METHOD; TUMOR NECROSIS FACTOR-ALPHA;

RODENTIA;

EID: 0034454915     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.85.3.1316     Document Type: Review

References (22)

1. Insulin resistance
2. Causes of insulin resistance
3. Adipose expression of tumor necrosis factor-α. Direct role in obesity-linked insulin resistance
4. Tumor necrosis factor α. A key component of the obesity-diabetes link
5. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance
6. The expression of TNF-α by human muscle. Relationship to insulin resistance
7. Tumor necrosis factor-α in sera of obese patients: Fall with weight loss
8. Serum levels of tumor necrosis factor-α are increased in obese patients with non-insulin-dependent diabetes mellitus
9. Circulating tumor necrosis factor-α concentrations in a native Canadian population with high rates of type 2 diabetes mellitus
10. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output
11. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans
12. Recombinant 55kDa TNF receptor. Stoichiometry of binding to TNF α and TNF β and inhibition of TNF activity
13. Protection from obesity-induced insulin resistance in mice lacking TNF-α function
14. Effects of an engineered human anti-TNF-α antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM
15. How to measure insulin action in vivo
16. Immunoassay of insulin with insulin antibody precipitate
17. Radioimmunological determination of human C-peptide in serum
18. Immunoassays for glucagon
19. Enzymic determination of free fatty acids in serum
20. Indirect calorimetry
21. Tumor necrosis factor-α and hyperglycemia-induced insulin resistance. Evidence for different mechanisms and different effects on insulin signaling
22. Recombinant soluble tumor necrosis factor receptor (p80) fusion protein: Toxicity and dose finding trial in refractory rheumatoid arthritis